Sectoral Asset Management Inc Reata Pharmaceuticals Inc Transaction History

Sectoral Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$79.22 - $105.37 $1.78 Million - $2.37 Million	22,500 Added 90.0%	47,500 $4.84 Million
Q1 2023 May 12, 2023	BUY	$30.85 - $93.17 $771,250 - $2.33 Million	25,000 New	25,000 $2.27 Million
Q3 2020 Nov 13, 2020	SELL	$93.53 - $163.34 $336,708 - $588,024	-3,600 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$126.3 - $176.56 $8.89 Million - $12.4 Million	-70,409 Reduced 95.14%	3,600 $562,000
Q1 2020 May 13, 2020	SELL	$124.16 - $247.74 $824,546 - $1.65 Million	-6,641 Reduced 8.23%	74,009 $10.7 Million
Q4 2019 Feb 12, 2020	BUY	$74.57 - $217.92 $6.01 Million - $17.6 Million	80,650 New	80,650 $16.5 Million

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Sectoral Asset Management Inc with notifications on news.